Study Stopped
Preliminary data analysis underway, will determine whether additional recruitment is necessary upon review of collected data.
Early Prevention of PTSD in Patients Within One Week of Acute Physical Trauma
A Pilot Randomized Controlled Trial in Patients Within One Week of Acute Physical Trauma to Test the Feasibility and Effectiveness of AEPET Plus RBT Versus RBT Alone for the Prevention of PTSD and Depression
1 other identifier
interventional
20
1 country
1
Brief Summary
The objective of this study is to assess the feasibility and effectiveness of AEPET plus Resilience Based Therapy (RBT) versus RBT alone for the prevention of PTSD and depression in trauma patients. The intervention group who have AEPET plus RBT will have reduced level of post traumatic stress symptoms and depression post sessions as well as reduced symptoms of PTSD and depression at 4- 6 weeks as compared to the control group who have -"Resilience Based" less specific supportive therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 14, 2016
CompletedFirst Posted
Study publicly available on registry
September 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedDecember 5, 2024
December 1, 2024
7.5 years
July 14, 2016
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD Presence and Severity at 1 month follow-up
Scale used to assess presence and measure severity: The Post-Traumatic Stress Disorder (PTSD) Symptom Scale -Interview (PSS-I)
1 - 2 Months
Secondary Outcomes (4)
Change from Baseline Trauma-related Thoughts and Beliefs at Therapy Time-Point 2 and 1 month follow-up
1 - 2 Months
Change from Baseline Depresssive Symptoms at Therapy Time-Point 2 and 1 month follow-up
1 - 2 Months
PTSD Presence and Severity and Diagnosis at 1 month follow-up
1 - 2 Months
Psychological Well-being at 1 month follow-up
1 - 2 Months
Study Arms (2)
Treatment As Usual + Resilience-Based Supportive Therapy
NO INTERVENTIONRoutine psychosocial management of trauma patients, including Manualized Resilience-Based Therapy.
Abbreviated Early Prolonged Exposure Therapy
EXPERIMENTALAEPET, including Manualized Resilience-Based supportive Therapy.
Interventions
Since many trauma patients are discharged within 4 weeks, AEPET with the same length (45 minutes - 1 hour) and number of sessions as PET, is given in a shorter time period (daily for 3 days as opposed to weekly over 3 weeks).
Eligibility Criteria
You may qualify if:
- Age 17-75
- Experienced an acute physical trauma in the past 4 days where the patient believed it was potentially life-threatening in their mind at the time of the trauma
- Have some clear memories of the trauma
- Contain any risk factors for PTSD
- An abbreviated Injury Severity (AIS) score of 1-3 (Minor, Moderate and Severe; not life threatening)
You may not qualify if:
- Inability to communicate sufficiently in English to be able to complete questionnaires and provide informed consent
- A diagnosis of psychosis, mental retardation or autism
- Blood alcohol level of \>0.08mmol/L (25 mg/dl) at time of admission
- Cognitive impairment apparent on interview/collateral from trauma team
- Severe head injury
- Withdrawal Criteria
- If the patient is thought to be at risk to self or others, or be in need of immediate psychiatric assessment, in which case the patient will be referred urgently for assessment with psychosocial oncology or department of psychiatry
- If the patient wishes to discontinue the study
- If the patient is noted to be cognitively impaired during the course of the study such that he/she cannot complete a questionnaire reliably or physically impaired such that it is too burdensome for the patient to complete the questionnaire package.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janet Ellis, MD
Sunnybrook Health Sciences Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2016
First Posted
September 27, 2016
Study Start
February 1, 2016
Primary Completion
August 1, 2023
Study Completion
August 1, 2025
Last Updated
December 5, 2024
Record last verified: 2024-12